0001434418-16-000002.txt : 20160927 0001434418-16-000002.hdr.sgml : 20160927 20160927102051 ACCESSION NUMBER: 0001434418-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160927 DATE AS OF CHANGE: 20160927 EFFECTIVENESS DATE: 20160927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-271333 FILM NUMBER: 161903550 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0707 D LIVE 0001434418 CONSTELLATION PHARMACEUTICALS INC 215 FIRST STREET SUITE 200 CAMBRIDGE MA MASSACHUSETTS 02142 617-714-0555 DELAWARE None None Corporation true Mark A. Goldsmith 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Anthony Evnin 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Director Peter Svennilson 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Director Tom Maniatis 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Director Robert Tepper 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Director James E. Audia 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Executive Officer Matthias Jaffe 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Executive Officer Michael R. Cooper 215 First Street Suite 200 Cambridge MA MASSACHUSETTS 02142 Executive Officer Biotechnology Decline to Disclose 06b false 2016-09-13 false true false 0 24298209 24298209 0 false 17 0 0 0 false CONSTELLATION PHARMACEUTICALS INC /s/ Mark Goldsmith Mark Goldsmith Chairman 2016-09-23